EMEA-001060-PIP01-10

Key facts

Active substance
(E)-4-(2-(6-(2-(2-(2-[18F]fluoroethoxy)ethoxy)ethoxy)pyridin-3-yl)vinyl)-N-methylbenzenamine
Therapeutic area
Diagnostic
Decision number
P/46/2011
PIP number
EMEA-001060-PIP01-10
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Diagnosis of Alzheimer's disease
Route(s) of administration
Intravenous use
Contact for public enquiries
Eli Lilly and Company Limited

E-mail: eu_paediatric@lilly.com
Tel. +44 (0)1276 4830 00

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating